ClinicalTrials.Veeva

Menu

Injectable Filler for Facial Soft Tissue Augmentation

P

Panaxia

Status

Completed

Conditions

Wrinkles

Study type

Observational

Funder types

Industry

Identifiers

NCT02218788
Hydroxytite p100:2013

Details and patient eligibility

About

The purpose of this study is to assess the safety and performance of Hydroxytite in all subjects who have received sub dermal or deep dermal injections.

Enrollment

218 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Patient is over 18 years of age
  • Patient received Hydroxytite injection(s).

Exclusion criteria

• Patient declines to participate in the study

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems